China Financial Statements From 2010 to 2026

SXTC Stock  USD 2.61  0.02  0.76%   
China SXT's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing China SXT's valuation are provided below:
Gross Profit
334.4 K
Market Capitalization
2.2 M
Enterprise Value Revenue
100.1378
Revenue
1.5 M
Earnings Share
(57.15)
We have found one hundred twenty available fundamental signals for China SXT Pharmaceuticals, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of China SXT's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road.

China SXT Total Revenue

1.49 Million

Check China SXT financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China SXT's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 4.4 K or Depreciation And Amortization of 89.9 K, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 10.7. China financial statements analysis is a perfect complement when working with China SXT Valuation or Volatility modules.
  
Build AI portfolio with China Stock
Check out the analysis of China SXT Correlation against competitors.

China SXT Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets22.1 M24.9 M16.4 M
Slightly volatile
Short and Long Term Debt Total2.2 M1.1 M1.5 M
Slightly volatile
Other Current Liabilities5.6 M3.4 MM
Slightly volatile
Total Current Liabilities10.7 M6.9 M8.4 M
Slightly volatile
Total Stockholder Equity11.3 M17.8 MM
Slightly volatile
Net Tangible Assets19.8 M18.8 M8.8 M
Slightly volatile
Property Plant And Equipment Net303.7 K319.7 K850.4 K
Pretty Stable
Current Deferred Revenue50.1 K52.8 K314.6 K
Slightly volatile
Accounts Payable1.4 MMM
Slightly volatile
Cash21.9 M20.8 MM
Slightly volatile
Non Current Assets Total401 K422.1 KM
Slightly volatile
Cash And Short Term Investments21.9 M20.8 MM
Slightly volatile
Net Receivables1.6 M1.7 M3.4 M
Very volatile
Common Stock Shares Outstanding487.7 K464.5 K153.8 K
Slightly volatile
Liabilities And Stockholders Equity22.1 M24.9 M16.4 M
Slightly volatile
Capital Surpluse9.6 M9.1 M5.1 M
Slightly volatile
Inventory796.1 K745.2 K1.2 M
Slightly volatile
Other Current Assets508.6 K422.3 K911.9 K
Slightly volatile
Other Stockholder Equity42.6 M40.6 M16.6 M
Slightly volatile
Total Liabilities10.8 M7.2 M8.5 M
Slightly volatile
Total Current Assets16.8 M24.5 M13.1 M
Slightly volatile
Short Term Debt843.6 K888 K1.4 M
Slightly volatile
Intangible Assets10.1 K10.6 K36.8 K
Slightly volatile
Common Stock53.8 M51.2 M9.1 M
Slightly volatile
Property Plant Equipment1.5 M1.8 M1.2 M
Slightly volatile
Non Currrent Assets OtherM9.6 M3.7 M
Slightly volatile
Common Stock Total Equity74.9 K71.4 K39.6 K
Slightly volatile
Property Plant And Equipment Gross2.5 M3.4 M1.7 M
Slightly volatile
Short and Long Term Debt776.7 K817.6 K1.1 M
Slightly volatile
Other Assets11.4 M10.9 M4.1 M
Slightly volatile
Short Term Investments129.7 K158.5 K119.8 K
Slightly volatile
Net Invested Capital16 M18.7 M10.4 M
Slightly volatile
Net Working Capital18.5 M17.6 MM
Slightly volatile
Other Liabilities33.4 K37.5 K41 K
Slightly volatile
Capital Stock53.8 M51.2 M9.1 M
Slightly volatile
Long Term Debt82.3 K110.7 K59.6 K
Slightly volatile

China SXT Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income4.4 K4.7 K23.1 K
Slightly volatile
Depreciation And Amortization89.9 K94.6 K156.5 K
Slightly volatile
Interest Expense744.4 K745.5 K500.8 K
Slightly volatile
Selling General Administrative2.9 M3.2 MM
Slightly volatile
Selling And Marketing Expenses316.7 K333.3 K530.9 K
Slightly volatile
Total Revenue1.5 M1.6 M3.7 M
Slightly volatile
Gross Profit314.1 K330.7 K1.4 M
Pretty Stable
Other Operating Expenses6.1 M5.1 M4.9 M
Slightly volatile
Cost Of Revenue1.7 M1.2 M2.3 M
Slightly volatile
Total Operating Expenses3.7 M3.5 M2.6 M
Slightly volatile
Reconciled Depreciation70.4 K74.1 K170.2 K
Pretty Stable
Research Development206.6 K220.1 K188 K
Slightly volatile

China SXT Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow8.3 M13.9 M5.8 M
Slightly volatile
Depreciation89.9 K94.6 K156.5 K
Slightly volatile
Capital Expenditures1.7 K1.8 K180.9 K
Pretty Stable
End Period Cash Flow21.9 M20.8 MM
Slightly volatile
Sale Purchase Of Stock5.2 M5.8 M6.4 M
Slightly volatile
Dividends Paid1.9 M2.1 M2.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10599.8676.4221
Slightly volatile
PTB Ratio10.711.26113
Slightly volatile
Days Sales Outstanding316359341
Slightly volatile
Book Value Per Share41.7643.96411
Slightly volatile
Average Payables1.8 M1.7 M1.7 M
Slightly volatile
Stock Based Compensation To Revenue0.20.210.6954
Slightly volatile
Capex To Depreciation0.02690.02831.2939
Slightly volatile
PB Ratio10.711.26113
Slightly volatile
EV To Sales10188.5573.8058
Slightly volatile
Inventory Turnover2.431.912.0537
Pretty Stable
Days Of Inventory On Hand142198187
Pretty Stable
Payables Turnover1.421.361.218
Pretty Stable
Sales General And Administrative To Revenue0.781.430.7362
Slightly volatile
Average Inventory981.3 K771.1 K983.8 K
Slightly volatile
Research And Ddevelopement To Revenue0.080.09890.0956
Very volatile
Capex To Revenue0.00130.00130.0351
Pretty Stable
Cash Per Share49.3351.92156
Pretty Stable
Days Payables Outstanding238277311
Slightly volatile
Intangibles To Total Assets6.0E-46.0E-40.0039
Slightly volatile
Current Ratio3.353.191.6834
Slightly volatile
Tangible Book Value Per Share41.7343.92398
Slightly volatile
Receivables Turnover1.291.051.2889
Slightly volatile
Shareholders Equity Per Share41.7643.96411
Slightly volatile
Debt To Equity0.06960.07330.3469
Slightly volatile
Capex Per Share0.00550.005839.2333
Slightly volatile
Average Receivables1.8 M1.9 M4.1 M
Very volatile
Revenue Per Share4.714.961.2 K
Slightly volatile
Interest Debt Per Share4.414.65225
Slightly volatile
Debt To Assets0.04960.05220.0872
Very volatile
Graham Number9041.7 K1.5 K
Slightly volatile
Operating Cycle458557528
Slightly volatile
Price Book Value Ratio10.711.26113
Slightly volatile
Days Of Payables Outstanding238277311
Slightly volatile
Ebt Per Ebit1.931.421.4947
Pretty Stable
Company Equity Multiplier2.961.614.3449
Slightly volatile
Long Term Debt To Capitalization0.00410.00560.0046
Slightly volatile
Total Debt To Capitalization0.06540.06890.2286
Slightly volatile
Debt Equity Ratio0.06960.07330.3469
Slightly volatile
Quick Ratio3.223.061.4896
Slightly volatile
Net Income Per E B T0.70.950.8621
Slightly volatile
Cash Ratio2.842.710.8786
Slightly volatile
Cash Conversion Cycle220280216
Slightly volatile
Days Of Inventory Outstanding142198187
Pretty Stable
Days Of Sales Outstanding316359341
Slightly volatile
Price To Book Ratio10.711.26113
Slightly volatile
Fixed Asset Turnover4.865.645.76
Slightly volatile
Debt Ratio0.04960.05220.0872
Very volatile
Price Sales Ratio10599.8676.4221
Slightly volatile
Asset Turnover0.08780.09240.3897
Slightly volatile
Gross Profit Margin0.450.240.3471
Slightly volatile
Price Fair Value10.711.26113
Slightly volatile

China Fundamental Market Drivers

China Upcoming Events

30th of October 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View

About China SXT Financial Statements

China SXT stakeholders use historical fundamental indicators, such as China SXT's revenue or net income, to determine how well the company is positioned to perform in the future. Although China SXT investors may analyze each financial statement separately, they are all interrelated. For example, changes in China SXT's assets and liabilities are reflected in the revenues and expenses on China SXT's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in China SXT Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue52.8 K50.1 K
Total Revenue1.6 M1.5 M
Cost Of Revenue1.2 M1.7 M
Stock Based Compensation To Revenue 0.21  0.20 
Sales General And Administrative To Revenue 1.43  0.78 
Research And Ddevelopement To Revenue 0.10  0.08 
Revenue Per Share 4.96  4.71 
Ebit Per Revenue(1.77)(1.68)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:
Check out the analysis of China SXT Correlation against competitors.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Will Personal Care Products sector continue expanding? Could China diversify its offerings? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every China SXT data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.426
Earnings Share
(57.15)
Revenue Per Share
3.895
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.18)
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, China SXT's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.